1-2 of 2
W. Knauf, MD
Close
Sort by
Journal Articles

Uptake of New Therapeutics in the Treatment of Multiple Myeloma (MM) in Germany (GER) - Results from a Representative Multicentre Treatment Survey 2006.

Ralf Angermund, MD, W. Knauf, MD, M. Freund, MD, M. Nowrousian, MD, H. Einsele, MD, H. Goldschmidt, MD, W. Berdel, MD, W. Poenisch, MD, C. Straka, MD, L. Kellermann, H. Pliskat, PhD
Journal: Blood
Blood (2006) 108 (11): 5110.
https://doi.org/10.1182/blood.V108.11.5110.5110
Published: 2006
Journal Articles

Cytogenetics and De Novo/Secondary AML but Not Age Are the Main Determinants for CR Rate and Hematological Recovery in Acute Myeloid Leukemia (AML) Using Intermediate Doses of Cytarabine (AraC) Delivered at the Presumptive Saturating Infusion Rate.

Cornelia Becker, MD, Haifa Al Ali, MD, Rainer Krahl, PhD, Wolfram Poenisch, MD, Dirk Hasenclever, PhD, Luisa Mantovani, MD, Mathias Freund, MD, R. Subert, MD, Ute Hegenbart, MD, Ulrich Wedding, MD, Johannes Meran, MD, Michael Herold, MD, Norma Peter, MD, W. Knauf, MD, Erika Kettner, MD, T. Ittel, MD, Astrid Franke, MD, K. Dachselt, MD, H.H. Wolf, MD, Ute Kreibich, MD, Manfred Schulze, MD, Michael Assmann, MD, Norbert Grobe, MD, Renate Huhn, MD, Ernst Zschuppe, MD, Veronika Schirmer, MD, U. Haak, MD, C. Klinkenstein, MD, B. Opitz, MD, Rita Pasold, MD, F. Fiedler, MD, C. Winkelmann, MD, Werner Helbig, MD, Dietger Niederwieser, MD
Journal: Blood
Blood (2005) 106 (11): 1851.
https://doi.org/10.1182/blood.V106.11.1851.1851
Published: 2005